Obinutuzumab en combinación con quimioterapia CHOP para CD20-positivo linfoma difuso de células B - primera línea

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2014
RECORD STATUS: This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. CITATION: NIHR HSC. Obinutuzumab in combination with CHOP chemotherapy for CD20-positive diffuse large B-cell lymphoma – first line. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon Scanning Review. 2014
Epistemonikos ID: c2b297c48723de8d7ef57a6ae1ee183632da0ac5
First added on: Feb 06, 2015